Explore more Articles in

Stock Sectors

Why Is Microcap Rallybio Stock Trading Higher On Tuesday? – Rallybio (NASDAQ:RLYB), Recursion Pharmaceuticals (NASDAQ:RXRX)

Rallybio Corporation RLYB agreed on Tuesday to sell its interest in REV102, an ENPP1 inhibitor in preclinical development for hypophosphatasia (HPP), to joint venture...

Top 3 Markets for Prop Traders: EUR/USD, Gold, and Nasdaq Explained

Thinking about prop trading but not sure where to kick things off? You’ve come to the right place. Prop firms want traders who can...

The Energy Report: So Much for Weak Demand

shook off the production increase as the physical market seems to be demanding more barrels. As we said before, OPEC’s production increase...

Novartis Gets Swiss Approval For First Malaria Drug For Babies – Novartis (NYSE:NVS)

Swissmedic, the Swiss Agency for Therapeutic Products, approved Novartis AG’s NVS Coartem (artemether-lumefantrine) Baby on Tuesday. This marks the first malaria medicine specifically approved...
BioTech

Obesity Drugs Help With Weight Loss But Are Adding Fat Elsewhere – Eli Lilly (NYSE:LLY)

A surge in demand for weight-loss and diabetes medications, paired with fears of incoming tariffs, has propelled Ireland to the center of a pharmaceutical...
BioTech

Analyst Downgrades Sarepta As Elevidys Safety Clouds Future Demand – Sarepta Therapeutics (NASDAQ:SRPT)

Earlier this week, Sarepta Therapeutics, Inc SRPT provided a safety update regarding Elevidys (delandistrogene moxeparvovec-rokl), the only approved gene therapy for patients with Duchenne...
BioTech

GH Research Submits Complete IND Hold Response to FDA Ahead of Schedule – GH Research (NASDAQ:GHRS)

DUBLIN, June 20, 2025 (GLOBE NEWSWIRE) -- GH Research PLC GHRS, a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients...
Energy Stocks

The Energy Report: Diesel and Gas

Diesel and gas are the leaders in the fall-out in Israel attack on Iran. The cutoff of Israel’s exports for a period and...
BioTech

FDA Approves Regeneron Sanofi Treatment For Rare Autoimmune Skin Disorder – Regeneron Pharmaceuticals (NASDAQ:REGN), Sanofi (NASDAQ:SNY)

The U.S. Food and Drug Administration (FDA) on Friday approved Regeneron Pharmaceuticals Inc. REGN and Sanofi SA’s SNY Dupixent (dupilumab) for adult patients with bullous pemphigoid...
BioTech

FDA Approves Gilead’s ‘Game Changing’ Twice-Yearly Shot To Prevent HIV Transmission, Critics Slam $28K Price Tag – Gilead Sciences (NASDAQ:GILD)

During market trading hours on Wednesday, the U.S. Food and Drug Administration (FDA) approved Gilead Sciences, Inc.’s GILD Yeztugo (lenacapavir) as pre-exposure prophylaxis (PrEP) to...
1...212223...29Page 22 of 29

- A word from our sponsors -

Most Popular

Disclaimer: The content provided is for informational purposes only. We aim to keep the content current and accurate by updating it frequently. Sometimes the actual data can differ from what's stated on our website. Buttonwoodnews.com is an independent platform. While we are independent, we may be compensated for advertisements, sponsored products, or when you click on a link on our website. The contributors and authors are not registered or certified financial advisors. You should consult a financial professional before making any financial decisions.

Copyright © Button Wood News.